Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) EBT (2016 - 2025)

INVO Fertility has reported EBT over the past 15 years, most recently at -$2.6 million for Q3 2025.

  • Quarterly EBT fell 65.14% to -$2.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$26.9 million through Sep 2025, down 263.35% year-over-year, with the annual reading at -$9.1 million for FY2024, 13.89% down from the prior year.
  • EBT was -$2.6 million for Q3 2025 at INVO Fertility, up from -$3.2 million in the prior quarter.
  • Over five years, EBT peaked at $101782.0 in Q4 2021 and troughed at -$17.4 million in Q1 2025.
  • The 5-year median for EBT is -$2.5 million (2021), against an average of -$3.0 million.
  • Year-over-year, EBT surged 102.67% in 2021 and then plummeted 2816.55% in 2022.
  • A 5-year view of EBT shows it stood at $101782.0 in 2021, then plummeted by 2816.55% to -$2.8 million in 2022, then grew by 28.69% to -$2.0 million in 2023, then tumbled by 86.51% to -$3.7 million in 2024, then rose by 28.09% to -$2.6 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's EBT are -$2.6 million (Q3 2025), -$3.2 million (Q2 2025), and -$17.4 million (Q1 2025).